Drawing for PARTNERIQ

USPTO serial 99166750

PARTNERIQ

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
SMITH, TARYN E
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with PARTNERIQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $649*

Plus Government fees of $750

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Felicia J. Boyd

Felicia J. Boyd Norton Rose Fulbright US LLP60 South Sixth Street, Suite 3100Minneapolis, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
035Price comparison services for the purpose of selecting the medicine that the member needs; Mail order pharmacy services; Mail order specialty pharmacy services; Retail specialty pharmacy services; Specialized retail pharmacy services for patients with particular medical conditions; Business management and consultation services in the field of specialty pharmacy; Pharmaceutical cost management services and drug utilization review services; Medical cost management; medical cost management in the field of pharmaceuticals; pharmaceutical and medical formulary management, namely, pharmaceutical costs analysis; Drug utilization review services; healthcare utilization review services; pharmaceutical cost management services; medical cost management services in the field of home delivery of prescription drugs; providing business intelligence services in the field of pharmacy benefit management; business services provided to the healthcare industry, namely, the collection, reporting, and analysis of data pertaining to pharmaceuticals and consumer behavior for business purposes; providing business management information in connection with business consulting and advisory services to the healthcare industry in the fields of prescription drug savings and reducing out-of-pocket costs and expenses for prescriptions; medical cost management consulting in the field of drug therapies, specifically, site of care and administration of drugs; business administration services, namely, negotiating business contracts with drug manufacturers to enable participant members of pharmacy benefit management clients to obtain discounts and rebates on pharmaceuticals; administration of a pharmacy discount program for enabling participants to obtain discounts on prescription drugs; administration of a discount program for enabling participants to obtain discounts on prescription drugs through the use of a discount membership card; Retail pharmacy services; pharmaceutical services, namely, processing and arranging for the delivery of online and telephone prescription orders via ground and air carriers in retail, mail order and central fill pharmacies; vendor and third party business management services for the pharmaceutical industry; providing information via a website in the field of pricing and discount information about pharmaceuticals from third party vendors and partnersACTIVE—
036Pharmacy benefit management services; providing a website featuring financial information to participants about third party vendors and partners regarding pharmaceutical costs and discountsACTIVE—
042Providing temporary use of online non-downloadable software for pharmacy spending management; providing temporary use of non-downloadable software for organizing, maintaining, and disseminating electronic medical and health records, and financial, clinical, and insurance information for use by physicians and clinics in business and office administration in the field of medical and clinical practice management systems accessible by means of a global computer network; providing temporary use of non-downloadable software for medical practice management and management of electronic health records; Providing a web site featuring technology that enables participant users to access an information and resources hub regarding third party vendors and partners relating to pharmaceutical costs and discountsACTIVE—
044Medical and pharmaceutical consultation; pharmaceutical advice; providing access to health professionals for advice and resources for treatment, medication, and support for medical conditions, namely, providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processed, exchanged and accessed in real-time by users; dispensing of pharmaceuticalsACTIVE—
045Providing information about legal eligibility requirements for government medical and pharmaceutical programs; providing patient advocate and case management services, namely, coordinating the procurement and administration of medication and medical services; providing health care coordination services being case management services, namely, coordinating medical services for patients to access specialty drug therapies; providing information about legal eligibility requirements in connection with pharmaceutical costs and discounts from third party vendors and partnersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 30, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 29, 2026EX1GSOU EXTENSION 1 GRANTED—
Sep 29, 2026EXT1SOU EXTENSION 1 FILED—
Sep 29, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 31, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 3, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 3, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 28, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 6, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 6, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Jan 6, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 6, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 6, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 10, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 10, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 10, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2025DOCKASSIGNED TO EXAMINER—
Sep 11, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 1, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
May 1, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance